Keros Therapeutics (KROS) Other Operating Expenses (2019 - 2020)
Keros Therapeutics (KROS) reported Other Operating Expenses of -$1.5 million for Q1 2020, down 146.69% on a YoY basis from $3.2 million in Q2 2019, and down 1810.26% quarter-over-quarter from -$78000.0 in Q4 2019.
Keros Therapeutics (KROS) Other Operating Expenses (2019 - 2020) Analysis & Trends
Keros Therapeutics has reported Other Operating Expenses for 2 years, with the latest figure at -$1.5 million in Q1 2020.
- For the quarter ending Q1 2020, Other Operating Expenses fell 146.69% year-over-year to -$1.5 million; the trailing twelve-month figure through Dec 2020 stood at -$1.5 million (up 41.89% YoY), and the FY2020 full-year result was -$1.5 million, up 41.89% from the prior year.
- Other Operating Expenses for Q1 2020 stood at -$1.5 million, down from -$78000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was -$78000.0 in Q4 2019, with the low at -$1.5 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Keros Therapeutics | 378.54 Mn | 91.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -1.49 Mn |
| Dec 31, 2019 | -78,000.00 |
| Sep 30, 2019 | -1.24 Mn |
| Jun 30, 2019 | -647,000.00 |
| Mar 31, 2019 | -604,000.00 |